Alois B. Lang

Dr. Alois B. Lang has been the Company’s Chief Development Officer from 2007 to 2017 before rejoining GeNeuro in September 2021. Dr. Lang holds a doctorate from the Ecole Polytechnique of Zurich and did postdoctoral work at the Zurich University Hospital and with the Immunology Department of Cetus Inc. in Palo Alto, United States. Dr. Alois B. Lang was also a professor of immunology at the Faculté de médecine (medical school) of the University of Berne. He held the position of Chief of Research and Immunology and Project Director for Berna Biotech, in Berne. He was also co-founder and Scientific Director of Kenta Biotech in Zurich.

Dr. Alois B. Lang is involved in various working groups with scientific experts and regularly participates in major scientific conferences.